US Computed Tomography Market Research Report By Types (Conventional Scanners, Cone Beam Scanners), By Applications, By End Users, by Distribution Channel Forecast till 2032

Description

List of Tables

The US Computed Tomography Market is anticipated to witness steady growth, expanding from USD 1,353.87 million in 2025 to USD 2,521.75 million by 2032. Growing at a CAGR of 7.07% from 2025 to 2032, the market growth is supported by technological advancements and the increasing prevalence of chronic diseases.

Increasing Need for Early Disease Detection Supporting Market Growth

Due to the rise of chronic conditions in the U.S., the healthcare ecosystem has been under pressure to look for advanced imaging solutions that can provide fast as well as accurate diagnosis. This increasing focus on preventive healthcare as well as on the timely detection of diseases is, in turn, helping the market for CT imaging systems in the U.S.

Key Insights Across Market Segments

By Types

Conventional Scanners (Low Slice) - Suitable for basic and affordable imaging needs.
Conventional Scanners (Medium Slice) - Delivers efficient imaging with moderate throughput.
Conventional Scanners (High Slice) - Advanced systems supporting rapid diagnostic imaging.
Cone Beam Scanners - Provides high-resolution images with lower radiation exposure.

By Applications

Oncology - Critical for tumor identification and treatment planning.
Neurology - Enhances diagnosis of neurological disorders and injuries.
Cardiovascular - Improves visualization of heart and vascular structures.
Musculoskeletal - Commonly utilized for orthopedic diagnostic evaluations.
Abdominal and Pelvic - Supports accurate abdominal disease diagnosis procedures.
Others - Broader applications continue expanding across healthcare sectors.

By End Users

Hospitals - Strong adoption driven by advanced healthcare infrastructure.
Specialty Centres - Increasing preference for specialized diagnostic imaging services.
Diagnostic and Imaging Centre - Rising patient preference for standalone imaging centres.

By Distribution Channel

Online Channels - Digital purchasing channels gaining steady market traction.
Offline Channels - Direct sales channels continue driving equipment distribution.

Advancing Next-Generation CT Imaging Solutions

In December 2024, Siemens Healthineers expanded its Naeotom Alpha class portfolio with the launch of Naeotom Alpha.Pro and Naeotom Alpha.Prime scanners. The introduction of advanced dual-source and photon-counting CT technologies highlights the company's focus on enhancing imaging precision, workflow efficiency, and next-generation diagnostic capabilities.

Rising Importance of Point-of-Care Diagnostics

POC CT systems are becoming increasingly popular in the US as healthcare providers focus on faster and more accessible diagnostic solutions. By enabling clinical decision-making in real-time, these devices are not only saving lives but also significantly boosting the quality of patient management and treatment outcomes.

Key Report Attributes

Market Size 2025: USD 1,353.87 Million
Market Size 2032: USD 2,521.75 Million
CAGR (2025-2032): 7.07%
Base Year: 2024
Market Forecast Period: 2025-2032

Industry segmentations Growth

By Types: Conventional Scanners - 6.99%, Cone Beam Scanners - 8.54%.
By Applications: Oncology - 7.39%, Neurology - 8.79%.
By End Users: Hospitals - 6.90%, Specialty Centres - 5.66%.
By Distribution Channel: Online Channels - 8.07%, Offline Channels - 6.30%.

Product Code: MRFRHC62413CR

1 EXECUTIVE SUMMARY

2 MARKET INTRODUCTION

2.1 DEFINITION
2.2 SCOPE OF THE STUDY
2.3 RESEARCH OBJECTIVE
2.4 MARKET STRUCTURE

3 RESEARCH METHODOLOGY

3.1 OVERVIEW
3.2 DATA FLOW
- 3.2.1 DATA MINING PROCESS
3.3 PURCHASED DATABASE:
3.4 SECONDARY SOURCES:
- 3.4.1 SECONDARY RESEARCH DATA FLOW:
3.5 PRIMARY RESEARCH:
- 3.5.1 PRIMARY RESEARCH DATA FLOW:
- 3.5.2 PRIMARY RESEARCH: NUMBER OF INTERVIEWS CONDUCTED
3.6 APPROACHES FOR MARKET SIZE ESTIMATION:
- 3.6.1 REVENUE ANALYSIS APPROACH
3.7 DATA FORECASTING
- 3.7.1 DATA FORECASTING TYPE
3.8 DATA MODELING
- 3.8.1 MICROECONOMIC FACTOR ANALYSIS:
- 3.8.2 DATA MODELING:
3.9 TEAMS AND ANALYST CONTRIBUTION

4 MARKET DYNAMICS

4.1 INTRODUCTION
4.2 DRIVERS
- 4.2.1 INCREASING INCIDENCES OF CHRONIC DISEASES
- 4.2.2 EXPANSION OF CT IN TRAUMA & EMERGENCY CARE
4.3 RESTRAINTS
- 4.3.1 SHORTAGE OF SKILLED RADIOLOGISTS AND TECHNICIANS
- 4.3.2 COMPETITION FROM ALTERNATIVE IMAGING MODALITIES
4.4 OPPORTUNITY
- 4.4.1 AI INTEGRATION IN CT IMAGING
- 4.4.2 GROWING DEMAND FOR PORTABLE & POINT-OF-CARE CT SCANNERS

5 MARKET FACTOR ANALYSIS

5.1 PORTER'S FIVE FORCES MODEL
- 5.1.1 THREAT OF NEW ENTRANTS
- 5.1.2 BARGAINING POWER OF SUPPLIERS
- 5.1.3 THREAT OF SUBSTITUTES
- 5.1.4 BARGAINING POWER OF BUYERS
- 5.1.5 INTENSITY OF RIVALRY
5.2 IMPACT OF COVID-19 ON US COMPUTED TOMOGRAPHY (CT) MARKET
5.3 MARKET TRENDS ON US COMPUTED TOMOGRAPHY (CT) MARKET
5.4 REGULATORY FRAMEWORK
5.5 TECHNOLOGICAL ADVANCEMENTS
5.6 PRICING ANALYSIS, 2023 (USD)
5.7 LIST OF DISTRIBUTORS OF COMPUTED TOMOGRAPHY (CT) SCANNERS IN THE US
5.8 LIST OF POTENTIAL CUSTOMERS IN THE US
5.9 TOTAL NUMBER OF COMPUTED TOMOGRAPHY (CT) INSTALLATION IN US (2019-2032)

6 US COMPUTED TOMOGRAPHY (CT) MARKET, BY TYPE

6.1 OVERVIEW
6.2 CONVENTIONAL SCANNERS
6.3 CONE BEAM SCANNERS

7 US COMPUTED TOMOGRAPHY (CT) MARKET, BY APPLICATION

7.1 OVERVIEW
7.2 ONCOLOGY
7.3 NEUROLOGY
7.4 CARDIOVASCULAR
7.5 MUSCULOSKELETAL
7.6 ABDOMINAL & PELVIC
7.7 OTHERS

8 US COMPUTED TOMOGRAPHY (CT) MARKET, BY END USER

8.1 OVERVIEW
8.2 HOSPITALS
8.3 SPECIALTY CENTERS
8.4 DIAGNOSTIC AND IMAGING CENTER

9 US COMPUTED TOMOGRAPHY (CT) MARKET, BY DISTRIBUTION CHANNEL

9.1 OVERVIEW
9.2 ONLINE
9.3 OFFLINE

10 US COMPUTED TOMOGRAPHY (CT) MARKET, BY REGION

10.1 OVERVIEW
10.2 NORTHEAST
- 10.2.1 NEW YORK
- 10.2.2 PENNSYLVANIA
- 10.2.3 MASSACHUSETTS
- 10.2.4 REST OF NORTHEAST
10.3 MIDWEST
- 10.3.1 ILLINOIS
- 10.3.2 OHIO
- 10.3.3 MICHIGAN
- 10.3.4 REST OF MIDWEST
10.4 SOUTH
- 10.4.1 TEXAS
- 10.4.2 FLORIDA
- 10.4.3 GEORGIA
- 10.4.4 REST PF SOUTH
10.5 WEST
- 10.5.1 CALIFORNIA
- 10.5.2 WASHINGTON
- 10.5.3 ARIZONA
- 10.5.4 REST OF WEST

11 COMPETITIVE LANDSCAPE

11.1 INTRODUCTION
11.2 MARKET SHARE ANALYSIS, 2023
11.3 COMPETITOR DASHBOARD
11.4 PUBLIC PLAYERS STOCK SUMMARY
11.5 COMPARATIVE ANALYSIS: KEY PLAYERS FINANICAL
11.1 KEY DEVELOPMENTS & GROWTH STRATEGIES
- 11.1.1 PRODUCT LAUNCH
- 11.1.2 PRODUCT APPROVAL
- 11.1.3 EXPANSION
- 11.1.4 PARTNERSHIP
- 11.1.5 ACQUISITION

12 COMPANY PROFILE

12.1 SIEMENS HEALTHINEERS AG
- 12.1.1 COMPANY OVERVIEW
- 12.1.2 FINANCIAL OVERVIEW
- 12.1.3 PRODUCTS OFFERED
- 12.1.4 KEY DEVELOPMENTS
- 12.1.5 SWOT ANALYSIS
- 12.1.6 KEY STRATEGIES
12.2 SHIMADZU CORPORATION
- 12.2.1 COMPANY OVERVIEW
- 12.2.2 FINANCIAL OVERVIEW
- 12.2.3 PRODUCTS OFFERED
- 12.2.4 KEY DEVELOPMENTS
- 12.2.5 SWOT ANALYSIS
- 12.2.6 KEY STRATEGY
12.3 FUJIFILM HOLDINGS CORPORATION
- 12.3.1 COMPANY OVERVIEW
- 12.3.2 FINANCIAL OVERVIEW
- 12.3.3 PRODUCTS OFFERED
- 12.3.4 KEY DEVELOPMENTS
- 12.3.5 SWOT ANALYSIS
- 12.3.6 KEY STRATEGIES
12.4 MINDRAY
- 12.4.1 COMPANY OVERVIEW
- 12.4.2 FINANCIAL OVERVIEW
- 12.4.3 PRODUCTS OFFERED
- 12.4.4 KEY DEVELOPMENTS
- 12.4.5 KEY STRATEGIES
12.5 CANON MEDICAL SYSTEMS CORPORATION
- 12.5.1 COMPANY OVERVIEW
- 12.5.2 FINANCIAL OVERVIEW
- 12.5.3 PRODUCTS OFFERED
- 12.5.4 KEY DEVELOPMENTS
- 12.5.5 KEY STRATEGIES
12.6 GE HEALTHCARE
- 12.6.1 COMPANY OVERVIEW
- 12.6.2 FINANCIAL OVERVIEW
- 12.6.3 PRODUCTS OFFERED
- 12.6.4 KEY DEVELOPMENTS
- 12.6.5 SWOT ANALYSIS
- 12.6.6 KEY STRATEGIES
12.7 KONINKLIJKE PHILIPS N.V.
- 12.7.1 COMPANY OVERVIEW
- 12.7.2 FINANCIAL OVERVIEW
- 12.7.3 PRODUCTS OFFERED
- 12.7.4 KEY DEVELOPMENTS
- 12.7.5 SWOT ANALYSIS
- 12.7.6 KEY STRATEGIES
12.8 STRYKER
- 12.8.1 COMPANY OVERVIEW
- 12.8.2 FINANCIAL OVERVIEW
- 12.8.3 PRODUCTS OFFERED
- 12.8.4 KEY DEVELOPMENTS
- 12.8.5 SWOT ANALYSIS
- 12.8.6 KEY STRATEGIES
12.9 NEUROLOGICA CORP.
- 12.9.1 COMPANY OVERVIEW
- 12.9.2 FINANCIAL OVERVIEW
- 12.9.3 PRODUCTS OFFERED
- 12.9.4 KEY DEVELOPMENTS
- 12.9.5 KEY STRATEGIES
12.10 CARESTREAM DENTAL LLC
- 12.10.1 COMPANY OVERVIEW
- 12.10.2 FINANCIAL OVERVIEW
- 12.10.3 PRODUCTS OFFERED
- 12.10.4 KEY DEVELOPMENTS
- 12.10.5 KEY STRATEGIES

13 DATA CITATIONS